76
|
Nakamura M, Onozawa M, Motegi A, Hojo H, Zenda S, Nakamura N, Udagawa H, Kirita K, Matsumoto S, Umemura S, Yoh K, Niho S, Goto K, Akimoto T. P3.14-001 Impact of PCI on Prognosis of LD-SCLC Through Pattern of Brain Metastases as a First Recurrence Site. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
77
|
Hashimoto M, Nakamichi T, Fukuda A, Kuroda A, Takuwa T, Matsumoto S, Kondo N, Tsujimura T, Hasegawa S. P2.09-007 Pleural Biopsy in Patients Suspected of Malignant Pleural Mesothelioma Consecutive 377 Cases. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
78
|
Hashimoto M, Takuwa T, Kuroda A, Nakamichi T, Matsumoto S, Kondo N, Okumura Y, Tanaka F, Hasegawa S. P-127PLEURAL THICKNESS AFTER INDUCTION CHEMOTHERAPY IS SIGNIFICANTLY CORRELATED WITH PROGNOSIS IN PATIENTS UNDERGOING SURGERY FOR MALIGNANT PLEURAL MESOTHELIOMA. Interact Cardiovasc Thorac Surg 2017. [DOI: 10.1093/icvts/ivx280.127] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
79
|
Komatsu K, Matsumoto S. C8 nerve root schwannoma presenting as sudden-onset painful neuropathy: Utility of stir images. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3549] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
80
|
Tanaka K, Matsumoto S, Murai H, Yamasaki R, Kira J. Measurement conditions of end-diastolic ratio of common carotid arteries alter diagnostic ability for large artery intracranial occlusive disease. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2690] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
81
|
Yamashita T, Mitsuharu U, Misumi Y, Masuda T, Nomura T, Tasaki M, Matsumoto S, Takamatsu K, Obayashi K, Ando Y. Genetical and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas in japan. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
82
|
Koge J, Matsumoto S, Nakahara I, Ishii A, Hatano T, Sadamasa N, Kai Y, Ando M, Saka M, Chihara H, Takita W, Tokunaga K, Kamata T, Nishi H, Hashimoto T, Tsujimoto A, Kira J, Nagata I. Reduction in stroke alert response time for patients with in-hospital stroke using a standardized protocol. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
83
|
Satoi H, Matsumoto S. The study in our department for usefulness of the score for the targeting of atrial fibrillation (STAF) detecting atrial fibrillation in cerebral emboli. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
84
|
Akimitsu H, Ueda M, Tasaki M, Matsumoto S, Mizukami M, Misumi Y, Masuda T, Yamashita T, Obayashi K, Ando Y. A novel amyloid protein causing systemic venous amyloidosis in the elderly. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1983] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
85
|
Matsumoto S, Koyama H, Hatano T, Sadamasa N, Kai Y, Saka M, Ando M, Hashimoto T, Chihara H, Takita W, Tokunaga K, Kamata T, Tujimoto A, Nagata I, Kira J. The development of visual task management ICT system for acute stroke care. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
86
|
Kuroda A, Kondo N, Fukuda A, Nakamichi T, Hashimoto M, Takuwa T, Matsumoto S, Hasegawa S. P-268VALIDATION OF THE 8TH VERSION OF THE INTERNATIONAL MESOTHELIOMA INTEREST GROUP (IMIG) STAGING SYSTEM FOR MALIGNANT PLEURAL MESOTHELIOMA. Interact Cardiovasc Thorac Surg 2017. [DOI: 10.1093/icvts/ivx280.268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
87
|
Hashimoto Y, Komatsu K, Kouhashi M, Matsumoto S. Rapidly progressive noninfectious meningitis in a case of neuropsychiatric systemic lupus erythematosus. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
88
|
Ishikawa Y, Nakayama K, Morimoto M, Mizutani A, Nakayama A, Toyoshima K, Hayashi A, Takagi S, Dairiki R, Miyashita H, Matsumoto S, Gamo K, Nomura T, Nakamura K. Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication. Oncogenesis 2017; 6:e377. [PMID: 28892104 PMCID: PMC5623902 DOI: 10.1038/oncsis.2017.76] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2017] [Revised: 06/18/2017] [Accepted: 07/11/2017] [Indexed: 12/12/2022] Open
Abstract
Lysine-specific demethylase 1A (LSD1, KDM1A) specifically demethylates di- and monomethylated histones H3K4 and K9, resulting in context-dependent transcriptional repression or activation. We previously identified an irreversible LSD1 inhibitor T-3775440, which exerts antileukemic activities in a subset of acute myeloid leukemia (AML) cell lines by inducing cell transdifferentiation. The NEDD8-activating enzyme inhibitor pevonedistat (MLN4924, TAK-924) is an investigational drug with antiproliferative activities in AML, and is also reported to induce cell differentiation. We therefore tested the combination of these two agents in AML models. The combination treatment resulted in synergistic growth inhibition of AML cells, accompanied by enhanced transdifferentiation of an erythroid leukemia lineage into granulomonocytic-like lineage cells. In addition, pevonedistat-induced rereplication stress during the S phase was greatly augmented by concomitant treatment with T-3775440, as reflected by the increased induction of apoptosis. We further demonstrated that the combination treatment was markedly effective in subcutaneous tumor xenograft models as well as in a disseminated model of AML, leading to tumor eradication or prolonged survival in T-3775440/pevonedistat cotreated mice. Our findings indicate the therapeutic potential of the combination of LSD1 inhibitors and pevonedistat for the treatment of AML.
Collapse
|
89
|
Tamura T, Sakai D, Sugimoto N, Tokunaga S, Tsuji A, Ishida H, Otsu S, Moriwaki T, Satake H, Uchino K, Matsumoto S, Baba E, Sato M, Taniguchi H, Kishimoto J, Boku N, Hyodo I, Muro K. Predictive value of primary tumor location: Results from randomized phase II study of panitumumab + irinotecan versus cetuximab + irinotecan in patients with KRAS exon2 wild-type metastatic colorectal cancer (WJOG6510G). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx393.109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
90
|
Usui Y, Kirita K, Matsumoto S, Ohe Y, Nishio M, Seto T, Kodani M, Taima K, Hattori Y, Kohno T, Yoh K, Goto K. Detectability of RET fusions by amplicon-based next generation sequencing in nationwide lung cancer genomic screening project: LC-SCRUM-Japan. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
91
|
Matsumoto S, Watanabe I, Nakanishi R, Fujino T, Ikeda F. P2719Heart rate during hypothermia therapy is an independent predictor of clinical outcomes in patients resuscitated from out-of-hospital cardiac arrest due to acute coronary syndrome. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p2719] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
92
|
Nakatani M, Migita K, Matsumoto S, Wakatsuki K, Ito M, Nakade H, Kunishige T, Kitano M, Kanehiro H. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy. Dis Esophagus 2017; 30:1-7. [PMID: 28575242 DOI: 10.1093/dote/dox020] [Citation(s) in RCA: 56] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/21/2016] [Accepted: 03/06/2017] [Indexed: 12/11/2022]
Abstract
Nutritional status is one of the most important issues faced by cancer patients. Several studies have shown that a low preoperative nutritional status is associated with a worse prognosis in patients with various types of cancer, including esophageal cancer (EC). Recently, neoadjuvant chemotherapy (NAC) and/or radiotherapy have been accepted as the standard treatment for resectable advanced EC. However, NAC has the potential to deteriorate the nutritional status of a patient. This study aimed to evaluate the prognostic significance of the nutritional status for EC patients who underwent NAC. We retrospectively reviewed 66 squamous cell EC patients who underwent NAC consisting of docetaxel, cisplatin, and 5-fluorouracil followed by subtotal esophagectomy at Nara Medical University Hospital between January 2009 and August 2015. To assess the patients' nutritional status, the prognostic nutritional index (PNI) before commencing NAC and prior to the operation was calculated as 10 × serum albumin (g/dl) + 0.005 × total lymphocyte count in the peripheral blood (per mm3). The cutoff value of the PNI was set at 45. A multivariable analysis was performed to identify prognostic factors for overall survival (OS) and relapse-free survival (RFS). The mean pre-NAC and preoperative PNI were 50.2 ± 5.7 and 48.1 ± 4.7, respectively (P = 0.005). The PNI decreased following NAC in 44 (66.7%) patients. Before initiating NAC, 9 (13.6%) patients had a low PNI, and 12 (18.2%) patients had a low PNI prior to the operation. The pre-NAC PNI and preoperative PNI were significantly associated with the OS (P = 0.013 and P = 0.004, respectively) and RFS (P = 0.036 and P = 0.005, respectively) rates. The multivariable analysis identified the preoperative PNI as an independent prognostic factor for poor OS and RFS, although the pre-NAC PNI was not an independent predictor. Our results suggest that the preoperative PNI is a useful marker for predicting the long-term outcomes of EC patients undergoing NAC and subsequent subtotal esophagectomy. Therefore, patients with a low preoperative nutritional status may be at a higher risk of EC recurrence.
Collapse
|
93
|
Toya C, Muramoto H, Iwai S, Higuchi K, Tsunamoto H, Matsumoto S, Ozawa T, Araki K, Ohnishi T, Kobayashi I, Ohnishi Y, Umezawa S, Niwa A, Hirao K. 1680The assessment of left atrial appendage flow by computed tomography using serial snapshots method. Europace 2017. [DOI: 10.1093/ehjci/eux160.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
94
|
Higuchi K, Toya C, Iwai S, Muramoto H, Tsunamoto H, Matsumoto S, Ozawa T, Onishi T, Kobayashi I, Onishi Y, Umezawa S, Niwa A, Yokoyama Y, Hirao K. P871Changes in continuous wavelet transform of left atrium before and after pulmonary vein isolation in patients with persistent atrial fibrillation. Europace 2017. [DOI: 10.1093/ehjci/eux151.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
95
|
Iwai S, Higuchi K, Toya C, Muramoto H, Tsunamoto H, Matsumoto S, Ozawa T, Araki K, Onishi T, Kobayashi I, Onishi Y, Umezawa S, Niwa A, Hirao K. P1401Distributions and correlation of left atrial low voltage zone detected by high density multi-electrode catheter during atrial fibrillation and sinus rhythm. Europace 2017. [DOI: 10.1093/ehjci/eux158.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
96
|
Iwai S, Higuchi K, Toya C, Muramoto H, Tsunamoto H, Matsumoto S, Ozawa T, Araki K, Onishi T, Kobayashi I, Onishi Y, Umezawa S, Niwa A, Hirao K. P934The electroanatomical characteristics of the patients who need epicardial coronary sinus approach for complete conduction block along mitral isthmus. Europace 2017. [DOI: 10.1093/ehjci/eux151.116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
97
|
Toya C, Higuchi K, Iwai S, Hirotaka M, Tsunamoto H, Matsumoto S, Ozawa T, Araki K, Ohnishi T, Kobayashi I, Ohnishi Y, Umezawa S, Niwa A, Yokoyama Y, Hirao K. P341Comparison of locations between continuous wavelet transform analysis and complex fractionated atrial electrogram in patients with persistent atrial fibrillation. Europace 2017. [DOI: 10.1093/ehjci/eux141.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
98
|
Okusaka T, Miyakawa H, Fujii H, Nakamori S, Satoh T, Hamamoto Y, Ito T, Maguchi H, Matsumoto S, Ueno H, Ioka T, Boku N, Egawa S, Hatori T, Furuse J, Mizumoto K, Ohkawa S, Yamaguchi T, Yamao K, Funakoshi A, Chen JS, Cheng AL, Sato A, Ohashi Y, Tanaka M. Updated results from GEST study: a randomized, three-arm phase III study for advanced pancreatic cancer. J Cancer Res Clin Oncol 2017; 143:1053-1059. [PMID: 28210843 PMCID: PMC5427167 DOI: 10.1007/s00432-017-2349-y] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2016] [Accepted: 01/24/2017] [Indexed: 01/05/2023]
Abstract
PURPOSE The GEST study showed non-inferiority of S-1 but not superiority of gemcitabine plus S-1 (GS) to gemcitabine alone for overall survival with the data by the cut-off date of 31st July in 2010 for chemo-naïve patients with advanced pancreatic cancer. We considered it important to determine whether S-1 maintains non-inferiority after a long-term follow-up in the GEST study and to obtain a firm positive conclusion. In addition, it may be an interesting challenge to explore the efficacious profile of GS in the long-term follow-up study. Using the data from the follow-up period, background and efficacy in patients from Taiwan and Japan, as well as the rates of tumor shrinkage in locally advanced and metastatic patients (Waterfall plot) were also analyzed. METHODS The results of the primary analysis were reconfirmed, and subset analysis of overall survival and progression-free survival was performed based on the overall survival data updated by the cut-off date of 31st July in 2011. RESULTS The median follow-up period was 29.8 months, and 795 deaths occurred (95.6%). The median overall survival was 8.8 months for gemcitabine, 9.7 months for S-1 (hazard ratio [HR], 0.96; 97.5% confidence interval [CI], 0.79-1.17), and 9.9 months for GS (HR 0.91; 97.5% CI 0.75-1.11). In patients with performance status (PS) 0, the median overall survival was 9.8 months for gemcitabine, 10.9 months for S-1, and 10.5 months for GS. In patients with PS 1, the median overall survival was 6.2 months for gemcitabine, 6.3 months for S-1, and 9.6 months for GS. CONCLUSION Our survey reconfirmed the non-inferiority of S-1 to gemcitabine and showed S-1 can be used as one of the standard treatment options for advanced pancreatic cancer. TRIAL REGISTRATION ClinicalTrials.gov: NCT00498225.
Collapse
|
99
|
Kirita K, Udagawa H, Matsumoto S, Umemura S, Yoh K, Niho S, Goto K. 453P Utility of re-biopsy and clinical predictive factors of T790M point mutation in EGFR mutated non-small lung cancer. Ann Oncol 2016. [DOI: 10.1016/s0923-7534(21)00611-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
100
|
Kirita K, Udagawa H, Matsumoto S, Umemura S, Yoh K, Niho S, Goto K. 453P Utility of re-biopsy and clinical predictive factors of T790M point mutation in EGFR mutated non-small lung cancer. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw594.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|